Every stock has it's buy price, but CYP is still an early stage copy of MSB with manufactured cells. The FDA can't get their head around naturally derived cells yet, so look at 10 years maybe as this journey has already been 20 years and just about to be approved.
Ann: Cynata secures commitments for $8.1m institutional placement, page-62
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.5¢ | $45.77K | 277.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1313831 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 51027 | 3 |
View Market Depth
| Last trade - 14.16pm 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |